Fingerprint
Dive into the research topics of 'Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically